MedWatch

GN Hearing top exec stops after 17 years – replacement found within own ranks

The CEO of hearing company GN Hearing's US subsidiary Audigy is now retiring after 17 years in the hot seat. The company, which was acquired by GN Hearing in 2016, has found his replacement within own ranks.

Photo: Mason Walker, PR

After having led GN Hearing's US subsidiary Audigy for almost two decades, Brandon Dawson has resigned from the post of CEO in order to retire, according to a press release from Washington-based Audigy.

The now-former top exec is being replaced by Mason Walker, who has been involved in Audigy since the early beginnings of the company. His promotion is from President to CEO.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs